Medi-Caps Limited (NSE:MEDICAPQ)
India · Delayed Price · Currency is INR 25.09
-0.25 (-0.99%)
At close: Sep 23, 2026
Medi-Caps Ratios and Metrics
Market cap in millions INR. Fiscal year is April - March.
Millions INR. Fiscal year is Apr - Mar.
Total Valuation
Fiscal Year | Current | FY 2026 | FY 2025 | FY 2024 | FY 2023 | FY 2022 |
|---|---|---|---|---|---|---|
Period Ending | Sep '26 Sep 22, 2026 | Mar '26 Mar 31, 2026 | Mar '25 Mar 31, 2025 | Mar '24 Mar 31, 2024 | Mar '23 Mar 31, 2023 | Mar '22 Mar 31, 2022 |
| 314 | 289 | 518 | 553 | 436 | 619 | |
Market Cap Growth | -36.60% | -44.11% | -6.36% | 26.91% | -29.65% | 23.05% |
Enterprise Value | 75 | 39 | 182 | 278 | 157 | 235 |
Price Ratios
Fiscal Year | Current | FY 2026 | FY 2025 | FY 2024 | FY 2023 | FY 2022 |
|---|---|---|---|---|---|---|
Period Ending | Sep '26 Sep 22, 2026 | Mar '26 Mar 31, 2026 | Mar '25 Mar 31, 2025 | Mar '24 Mar 31, 2024 | Mar '23 Mar 31, 2023 | Mar '22 Mar 31, 2022 |
PE Ratio | - | - | - | - | 24.81 | 6.14 |
PS Ratio | 2.50 | 2.32 | 2.03 | 2.02 | 0.88 | 0.89 |
PB Ratio | 0.28 | 0.26 | 0.43 | 0.46 | 0.37 | 0.53 |
P/TBV Ratio | 0.38 | 0.35 | 0.56 | 0.60 | 0.48 | 0.70 |
P/FCF Ratio | - | - | 10.91 | 8.39 | - | 14.65 |
P/OCF Ratio | - | - | 10.21 | 7.97 | - | 8.82 |
EV Ratios
Fiscal Year | Current | FY 2026 | FY 2025 | FY 2024 | FY 2023 | FY 2022 |
|---|---|---|---|---|---|---|
Period Ending | Sep '26 Sep 22, 2026 | Mar '26 Mar 31, 2026 | Mar '25 Mar 31, 2025 | Mar '24 Mar 31, 2024 | Mar '23 Mar 31, 2023 | Mar '22 Mar 31, 2022 |
EV/Sales Ratio | 0.60 | 0.31 | 0.71 | 1.02 | 0.32 | 0.34 |
EV/EBITDA Ratio | - | - | - | - | 3.07 | 2.33 |
EV/EBIT Ratio | - | - | - | - | 4.74 | 2.87 |
EV/FCF Ratio | - | - | 3.83 | 4.22 | - | 5.56 |
Financial Efficiency
Fiscal Year | Current | FY 2026 | FY 2025 | FY 2024 | FY 2023 | FY 2022 |
|---|---|---|---|---|---|---|
Period Ending | Sep '26 Sep 22, 2026 | Mar '26 Mar 31, 2026 | Mar '25 Mar 31, 2025 | Mar '24 Mar 31, 2024 | Mar '23 Mar 31, 2023 | Mar '22 Mar 31, 2022 |
Net Debt / Equity Ratio | -0.21 | -0.27 | -0.28 | -0.29 | -0.31 | -0.32 |
Net Debt / EBITDA Ratio | 3.04 | 3.23 | 18.72 | 1032.69 | -7.06 | -3.63 |
Net Debt / FCF Ratio | - | 3.86 | -7.21 | -5.40 | 5.00 | -8.68 |
Asset Turnover | - | 0.10 | 0.20 | 0.22 | 0.39 | 0.57 |
Inventory Turnover | - | 1.97 | 2.52 | 1.49 | 2.42 | 3.25 |
Quick Ratio | - | 13.76 | 13.89 | 8.83 | 7.00 | 3.54 |
Current Ratio | - | 17.34 | 17.25 | 11.41 | 9.43 | 5.05 |
Return on Equity (ROE) | - | -2.61% | -0.47% | -1.87% | 1.59% | 9.09% |
Return on Assets (ROA) | - | -5.82% | -1.75% | -0.85% | 1.62% | 4.18% |
Return on Invested Capital (ROIC) | -11.47% | -13.33% | -4.11% | -2.05% | 1.55% | 10.84% |
Return on Capital Employed (ROCE) | - | -9.90% | -2.90% | -1.40% | 2.80% | 7.00% |
Yields
Fiscal Year | Current | FY 2026 | FY 2025 | FY 2024 | FY 2023 | FY 2022 |
|---|---|---|---|---|---|---|
Period Ending | Sep '26 Sep 22, 2026 | Mar '26 Mar 31, 2026 | Mar '25 Mar 31, 2025 | Mar '24 Mar 31, 2024 | Mar '23 Mar 31, 2023 | Mar '22 Mar 31, 2022 |
Earnings Yield | -5.66% | -10.50% | -1.10% | -4.05% | 4.03% | 16.28% |
FCF Yield | -25.05% | -27.20% | 9.16% | 11.93% | -16.63% | 6.83% |
Buyback Yield / Dilution | -0.08% | - | 0.00% | 0.00% | - | - |